The global healthcare industry is witnessing increasing attention toward bacterial infections caused by Enterobacteriaceae species due to the growing burden of antibiotic resistance and hospital acquired infections. Pharmaceutical companies, healthcare providers, and research institutions are investing heavily in advanced therapies and innovative antimicrobial solutions to improve patient...